Johnson CS - Search Results

1

Integrin activation suppresses etoposide-induced DNA strand breakage in cultured murine tumor-derived endothelial cells.

Hoyt DG, Rusnak JM, Mannix RJ, Modzelewski RA, Johnson CS, Lazo JS. Hoyt DG, et al. Among authors: johnson cs. Cancer Res. 1996 Sep 15;56(18):4146-9. Cancer Res. 1996. PMID: 8797583

2

Isolation and identification of fresh tumor-derived endothelial cells from a murine RIF-1 fibrosarcoma.

Modzelewski RA, Davies P, Watkins SC, Auerbach R, Chang MJ, Johnson CS. Modzelewski RA, et al. Among authors: johnson cs. Cancer Res. 1994 Jan 15;54(2):336-9. Cancer Res. 1994. PMID: 8275463

3

Interleukin 1 alpha and gamma-interferon induction of nitric oxide production from murine tumor-derived endothelial cells.

Chang MJ, Modzelewski RA, Russell DM, Johnson CS. Chang MJ, et al. Among authors: johnson cs. Cancer Res. 1996 Feb 15;56(4):886-91. Cancer Res. 1996. PMID: 8631029

4

Antiproliferative effects of 1alpha,25-dihydroxyvitamin D(3) and vitamin D analogs on tumor-derived endothelial cells.

Bernardi RJ, Johnson CS, Modzelewski RA, Trump DL. Bernardi RJ, et al. Among authors: johnson cs. Endocrinology. 2002 Jul;143(7):2508-14. doi: 10.1210/endo.143.7.8887. Endocrinology. 2002. PMID: 12072382

5

Potentiation by interleukin 1 alpha of cisplatin and carboplatin antitumor activity: schedule-dependent and pharmacokinetic effects in the RIF-1 tumor model.

Chang MJ, Yu WD, Reyno LM, Modzelewski RA, Egorin MJ, Erkmen K, Vlock DR, Furmanski P, Johnson CS. Chang MJ, et al. Among authors: johnson cs. Cancer Res. 1994 Oct 15;54(20):5380-6. Cancer Res. 1994. PMID: 7923169

6

Synergistic enhancement by interleukin-1 alpha of cisplatin-mediated antitumor activity in RIF-1 tumor-bearing C3H/HeJ mice.

Johnson CS, Chang MJ, Yu WD, Modzelewski RA, Grandis JR, Vlock DR, Furmanski P. Johnson CS, et al. Cancer Chemother Pharmacol. 1993;32(5):339-46. doi: 10.1007/BF00735916. Cancer Chemother Pharmacol. 1993. PMID: 8339383

7

Enhancement of 1,25-dihydroxyvitamin D3-mediated antitumor activity with dexamethasone.

Yu WD, McElwain MC, Modzelewski RA, Russell DM, Smith DC, Trump DL, Johnson CS. Yu WD, et al. Among authors: johnson cs. J Natl Cancer Inst. 1998 Jan 21;90(2):134-41. doi: 10.1093/jnci/90.2.134. J Natl Cancer Inst. 1998. PMID: 9450573

8

1,25-Dihydroxycholecalciferol (1,25-D3) inhibits the growth of squamous cell carcinoma and down-modulates p21(Waf1/Cip1) in vitro and in vivo.

Hershberger PA, Modzelewski RA, Shurin ZR, Rueger RM, Trump DL, Johnson CS. Hershberger PA, et al. Among authors: johnson cs. Cancer Res. 1999 Jun 1;59(11):2644-9. Cancer Res. 1999. PMID: 10363987

9

Calcitriol (1,25-dihydroxycholecalciferol) enhances paclitaxel antitumor activity in vitro and in vivo and accelerates paclitaxel-induced apoptosis.

Hershberger PA, Yu WD, Modzelewski RA, Rueger RM, Johnson CS, Trump DL. Hershberger PA, et al. Among authors: johnson cs. Clin Cancer Res. 2001 Apr;7(4):1043-51. Clin Cancer Res. 2001. PMID: 11309356

10

Gene therapy and endothelial cell targeting for cancer.

Evans RR, Calmels TP, Pitt BR, Brookens MA, Johnson CS, Modzelewski RA, Lazo JS. Evans RR, et al. Among authors: johnson cs. Ann N Y Acad Sci. 1994 May 31;716:257-64. doi: 10.1111/j.1749-6632.1994.tb21717.x. Ann N Y Acad Sci. 1994. PMID: 7517652 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

563 results

Search Page

Filters